These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1295722)
1. Activity of vancomycin against recently isolated nosocomial gram-positive cocci. Maccanti O; Bonadio M Drugs Exp Clin Res; 1992; 18(7):295-7. PubMed ID: 1295722 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]
3. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections]. Li JT; Li Y; Wang J; Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911 [TBL] [Abstract][Full Text] [Related]
4. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Huang YT; Liao CH; Teng LJ; Hsueh PR Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671 [TBL] [Abstract][Full Text] [Related]
5. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)]. Kayaokay Y; Hasçelik G; Gür D; Akalin E Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050 [TBL] [Abstract][Full Text] [Related]
6. Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004). Jones RN; Stilwell MG; Sader HS; Fritsche TR; Goldstein BP Diagn Microbiol Infect Dis; 2006 Feb; 54(2):149-53. PubMed ID: 16426793 [TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci]. Bezian MC; Ribou G; Masquelier B Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667 [TBL] [Abstract][Full Text] [Related]
8. [Surveillance of gram positive cocci susceptibility to betalactams, glycopeptides, and other antimicrobials]. Giglio MS; Farías O; Lafourcade M; Pinto ME Rev Med Chil; 1999 Aug; 127(8):919-25. PubMed ID: 10752252 [TBL] [Abstract][Full Text] [Related]
9. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006). Castanheira M; Jones RN; Sader HS Diagn Microbiol Infect Dis; 2008 Jun; 61(2):235-9. PubMed ID: 18314293 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece. Malli E; Spiliopoulou I; Kolonitsiou F; Klapsa D; Giannitsioti E; Pantelidi K; Pratti A; Panopoulou M; Grapsa S; Alepopoulou E; Neonakis I; Frantzidou F; Alexiou-Daniel S; Bakola D; Koutsia-Carouzou C; Malamou-Lada H; Zerva L; Vlahaki E; Kartali-Ktenidou S; Anastassiou ED; Petinaki E Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ; Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the antimicrobial resistance patterns of gram-positive cocci isolated from community-private and university-affiliated hospitals from Puerto Rico. Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermudez M; Colón M P R Health Sci J; 2003 Jun; 22(2):131-6. PubMed ID: 12866136 [TBL] [Abstract][Full Text] [Related]
17. Linezolid for the treatment of infections caused by Gram-positive pathogens in China. Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341 [TBL] [Abstract][Full Text] [Related]